Glander H J, Kratzsch J
Department of Dermatology, University of Leipzig, Germany.
Andrologia. 1997 Jan-Feb;29(1):23-8. doi: 10.1111/j.1439-0272.1997.tb03144.x.
In 41 men with idiopathic infertility, the effect of pure follicle-stimulating hormone (pFSH) therapy on semen parameters was evaluated in relation to the results of the gonadotrophin-releasing hormone (GnRH) stimulation test in an open study. The patients showed a mean (+/-standard error) sperm concentration of 15.84 (+/-2.87) Mill. ml-1, 41.02 (+/-4.19)% of the spermatozoa were motile and 46.16 (+/-2.36)% normomorph before treatment. All patients were administered 150 IU pFSH subcutaneously three times weekly for 10 weeks. After therapy with pFSH, no significant differences compared with the pre-treatment sperm characteristics were observed (P > 0.05) except for the velocity average path, VAP (P = 0.029). However, the stimulation factors of FSH in the GnRH test showed a significantly negative correlation with the pFSH mediated improvement of sperm concentration (r = -0.662, P = 0.000002), of percentage of normomorph spermatozoa (r = -0.480, P = 0.0015) and total count of motile spermatozoa per ejaculate (r = -0.567, P = 0.00014). In consequence, the patients were divided into two groups depending on the stimulation factor of hypophyseal FSH secretion, FSH-SF. The cut-off point of the FSH-SF was set at 1.7 because the correlation analyses detected a 1.5-fold improvement of sperm parameters at this hypophyseal response on average. Pure FSH treatment increased the concentration of spermatozoa (P = 0.0007), the total count of motile spermatozoa in the ejaculate (P = 0.015) as well as the computer-aided sperm motion parameters VAP (P = 0.029) and velocity curve linear, VCL (P = 0.049) in patients with FSH-SF < 1.7, whereas in the patient group with FSH-SF > 1.7 no improvement of semen parameters was found. Insufficient stimulation of hypophyseal FSH secretion may be a prerequisite but not a guarantee for responsiveness to pFSH treatment. The results of the present investigation suggest that FSH stimulation in the GnRH test should be taken into account in idiopathic infertile men before pFSH therapy.
在一项开放性研究中,对41名特发性不育男性患者,评估了纯卵泡刺激素(pFSH)治疗对精液参数的影响,并将其与促性腺激素释放激素(GnRH)刺激试验的结果相关联。治疗前,患者的精子浓度平均(±标准误)为15.84(±2.87)×10⁶/ml,41.02(±4.19)%的精子具有活力,46.16(±2.36)%的精子形态正常。所有患者每周皮下注射150IU pFSH,共3次,持续10周。pFSH治疗后,除平均路径速度(VAP)外(P = 0.029),与治疗前的精子特征相比,未观察到显著差异(P > 0.05)。然而,GnRH试验中FSH的刺激因子与pFSH介导的精子浓度改善(r = -0.662,P = 0.000002)、正常形态精子百分比(r = -0.480,P = 0.0015)以及每次射精活动精子总数(r = -0.567,P = 0.00014)呈显著负相关。因此,根据垂体FSH分泌的刺激因子(FSH-SF)将患者分为两组。FSH-SF的截断点设定为1.7,因为相关性分析发现,在此垂体反应水平下,精子参数平均提高了1.5倍。对于FSH-SF < 1.7的患者,纯FSH治疗可提高精子浓度(P = 0.0007)、射精活动精子总数(P = 0.015)以及计算机辅助精子运动参数VAP(P = 0.029)和曲线速度线性(VCL,P = 0.049),而在FSH-SF > 1.7的患者组中,未发现精液参数改善。垂体FSH分泌刺激不足可能是对pFSH治疗有反应的一个前提条件,但不是保证。本研究结果表明,在对特发性不育男性进行pFSH治疗之前,应考虑GnRH试验中的FSH刺激情况。